Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 1996

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

hydrocortisone

All Listed Sponsors
collaborator

Penn State University

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004669 - Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia | Biotech Hunter | Biotech Hunter